FDA Issues Draft Guidance for Accelerated Approval Confirmatory Clinical Trials
The FDA released a draft guidance document detailing their interpretation of when a confirmatory clinical trial for an accelerated approval is underway.
Related Articles
Phase 3 Study of Ameluz-PDT in Superficial Basal Cell Carcinoma Reaches 1-Year Follow-Up to Support FDA sNDA Submission
The phase 3 ALA-BCC-CT013 study of Ameluz and RhodoLED PDT in sBCC had its last enrolled patient complete a 1-year follow-up visit.
Cell-Based Therapies in GI Cancers: Current Landscape and Future Directions
Cell-based therapies have become integral to the routine clinical management of hematologic malignancies. Tumor-infiltrating lymphocyte (TIL) therapy has demonstrated efficacy in immunogenic solid tumors, such…
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Home | Lymphoma Hub
Online lymphoma resource for healthcare professionals, providing information, news & support relating to lymphoma, Hodgkin & non Hodgkin disease
Invikafusp Alfa Receives FDA Fast Track Designation for TMB-High CRC
Phase 1 data showed the potential for invikafusp alfa as a precision cancer immunotherapeutic agent in solid tumors after exposure to PD-(L)1 therapy.
17th Annual Hematologic Malignancies Demystified 2025 | Virtual
Register now for HMD 2025 and explore groundbreaking advancements in hematology. Stay informed with the latest innovations shaping the future of hematology research presented at…
Major breakthroughs in the field of BPDCN: combination therapies, managing CNS involvement & more
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly emerging disease. In this video, Naveen Pemmaraju, MD, The University of Texas MD Anderson…
Addressing potential biases in AI models for skin cancer diagnosis
Harald Kittler, MD, Medical University of Vienna, Vienna, Austria, highlights biases that could interfere with accurate diagnosis of skin cancers using artificial intelligence (AI) models.…
17th Annual Hematologic Malignancies Demystified 2025 | Virtual
Register now for HMD 2025 and explore groundbreaking advancements in hematology. Stay informed with the latest innovations shaping the future of hematology research presented at…